BIAL - Portela
Privately-held (family-owned) pharmaceutical company
Privately held: no public share price · Portugal
Assets
(3 total)
3Total Assets
2Approved
0Phase 3 / Filed
1Phase 1–2 / Early
3Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
Eslicarbazepine acetate(Aptiom) | Approved | Voltage-gated sodium channelSmall molecule | Epilepsy Focal Onset Seizures |
Opicapone(Ongentys) | Approved | COMTSmall molecule | Parkinson's Disease |
ZamicastatNo recent activity | Phase 2 | DBHSmall molecule | Pulmonary Arterial Hypertension |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.